BioPhausia generics news

BioPhausia will restructure and reduce headcount by about 10 (8%) to about 120 to focus on its operations in the Nordic region. The company will discontinue generic product operations in the Baltic and Poland and sell its Dutch generics business Ostwald Beheer B.V. (Voorschoten, the Netherlands) The company will continue generic operations in Poland related to repacking for external customers and BioPhausia's Cross Pharma AB subsidiary. Further details were not disclosed. ...